Role of Faecal Calprotectin in Patients With Abdominal Pain

Institute of Hospitalization and Scientific Care (IRCCS)

Status: Completed

Conditions: Inflammation

Treatments: Diagnostic Test: calprotectin levels

Study type: Observational

Funder types: Other

Identifiers

NCT05795985

4183

Details and patient eligibility

About

The evaluation of patients with abdominal pain is a challenge for the emergency physician and the selection of patients for second-level radiological examinations or endoscopic procedures is not always easy to perform. Faecal calprotectin could be a useful diagnostic marker to distinguish between "organic" or "functional" form and its determination could be helpful to select patients for further examinations, in the context of emergency setting.

Enrollment: 146 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients with abdominal pain and/or diarrhea and/or rectal bleeding

Exclusion criteria

• patients with age < 18 years
• pregnant women;
• patients with oncological, cardiological, nephrological terminal diseases;
• patients on antibiotic therapy or who have taken it during the last month;
• patients with a history of colic resection or gastrointestinal surgery;
• patients with a previous diagnosis of inflammatory bowel disease (Crohn's disease, ulcerative colitis)

Trial design

146 participants in 1 patient group

abdominal pain

Description:

patients with abdominal pain

Treatment:

Diagnostic Test: calprotectin levels